Smoking cessation interventions for patients with chronic obstructive pulmonary disease: A prospective study
Tobacco smoking is a primary contributor to chronic obstructive pulmonary disease, significantly impairing respiratory health. Understanding the risks of smoking and the benefits of cessation is vital for improving patient outcomes. The study aims to provide smoking cessation interventions for patients with chronic obstructive pulmonary disease (COPD), assess smoking indices and cessation status, develop Patient Information Leaflets (PILs), enhance medication adherence, and establish comprehensive smoking cessation guidelines. This prospective interventional study was conducted at a super specialty hospital over 12 months. A total of 128 participants were recruited, equally divided into an intervention group and a control group. Participants completed a questionnaire assessing their knowledge and willingness to quit smoking, followed by personalized counseling. The intervention group received individualized quit smoking programs, PILs, and used the 'Breathe Easy Diary' to track their progress and medication adherence. The intervention group exhibited a lower average smoking index (309.17) compared to the control group (463.23), with a statistically significant difference (p=0.042). The smoking cessation rate was significantly higher in the intervention group at 23.4%, versus 7.8% in the control group (p=0.015). Improved medication adherence was also noted in the intervention group.Personalized smoking cessation interventions significantly improved cessation rates, medication adherence, and reduced smoking indices in COPD patients, highlighting the need to address smoking behavior and health conditions to enhance quality of life.
Authors
- Shinu Cholamugath (ORCID: https://orcid.org/0000-0002-9504-9653)
Publication Details
- Journal
- Journal of medical pharmaceutical and allied sciences
- Published
- 2025-06-24
- DOI
- https://doi.org/10.55522/jmpas.v14i3.6761
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00